5 Explosive Growers to Buy or Watch: Heckmann Corporation (HEK), Spectrum Pharmaceuticals, Inc. (SPPI), Mesabi Trust (MSB)

Page 1 of 2

When seeking stocks for your portfolio, it makes sense to look for growing companies, and rapid growers understandably can be particularly enticing.

Below are a handful of companies with impressive revenue growth rates over the past three years. Why look at revenue growth? Well, while it’s true that the bottom-line profit might be most critical, it’s hard to grow your bottom line unless your top line is growing at a good clip.

Heckmann Corporation (NYSE:HEK)

Company 3-Year Annualized Revenue Growth
Brookfield Infrastructure Partners (NYSE:BIP)
271%
Heckmann Corporation (NYSE:HEK) 92%
Spectrum Pharmaceuticals (NASDAQ:SPPI) 85%
MAKO Surgical Corp. (NASDAQ:MAKO) 48%
Mesabi Trust (NYSE:MSB) 38%

Let’s take a quick look at each of these, so that you can get an idea of how interesting they are to you and whether you’d like to dig deeper into any of them.

Brookfield Infrastructure, recently yielding 4%, owns many valuable, and productive, assets such as coal terminals, railroads, dozens of port terminals, thousands of miles of natural gas transmission lines, thousands of miles of electricity transmission lines, hundreds of thousands of acres of timberlands, and much more. It operates toll roads and a coal terminal. It’s clearly rather diversified, operationally and geographically — for example, supplying some 98% of Chile’s electricity and being the sole provider of railroad services in Southwestern Western Australia. It’s also a defensive company, as many of its offerings, such as electricity, are not optional. It’s not perfect, but it has a lot to recommend it. The stock has averaged annual growth of 20% over the past five years.

Heckmann is a wastewater treatment and disposal specialist, and has been growing briskly in part due to its work serving the controversial fracking industry and its presence in just about every shale field. (The process of fracking consumes a lot of water, which must be supplied and treated.) Heckmann recently bought the Power Fuels company, expanding its energy services to include more liquid work instead of mainly gas. Heckmann has been unprofitable, but it has been turning that around. The stock has actually mostly fallen in recent years — that’s enough to keep some away, but it makes others wonder whether it’s attractively priced now. Its recent forward P/E of 35 coupled with a 25% estimated five-year growth rate suggest that it might not be quite a screaming buy.

Spectrum Pharmaceuticals is enjoying the success of its colorectal cancer drug, Fusilev — but that success has been partly due to a supply shortage faced by competition. Still, not every biotech company has products actually approved and selling in the market. And on top of that, Spectrum has more than a dozen other drugs in development in its pipeline, and has broadened its scope with the recent purchase of Allos Therapeutics, Inc. (NASDAQ:ALTH), which brought with it a lymphoma drug, Folotyn. The Allos buy is expected to deliver cost savings, too. Spectrum also recently secured rights for the bladder-cancer drug apaziquone and announced a special dividend. Some see the company as attractively valued as well as a possible acquisition target. For example, Spectrum’s share count has risen significantly, though the company plans to buy back shares, offsetting some of that.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!